Prenatal paternity tests work by collecting fetal DNA during pregnancy and comparing it to the potential father’s DNA. The most common method today is a simple blood draw from the mother’s arm, which can be done as early as 8 weeks into pregnancy. There are also two older, invasive methods that collect DNA directly from the uterus. All three approaches are highly accurate, but they differ in cost, timing, and risk.
How Fetal DNA Ends Up in the Mother’s Blood
The placenta sheds tiny fragments of DNA into the mother’s bloodstream throughout pregnancy. These fragments, called cell-free fetal DNA, carry the baby’s genetic information, which is a combination of the mother’s and father’s DNA. By around 7 to 8 weeks of pregnancy, enough of this fetal DNA is circulating for a lab to isolate and analyze it.
This is the basis of the noninvasive prenatal paternity test, often called NIPP. A technician draws blood from the mother’s arm, then takes a simple cheek swab from the potential father. The lab separates the fetal DNA from the mother’s own DNA in the blood sample, then checks thousands of genetic markers to see whether they match the potential father’s profile. If the markers align, paternity is confirmed. The entire process requires no needles near the uterus and poses zero risk to the pregnancy.
The Three Testing Methods
Noninvasive Prenatal Paternity (NIPP)
Available from week 8 onward, this is by far the most popular option. It requires only a blood draw from the mother and a cheek swab from the potential father. There is no risk of miscarriage, no sedation, and no recovery time. Research on the underlying technology shows that paternity can be accurately identified in virtually all samples collected after 7 weeks of pregnancy. Results typically come back within 5 to 7 business days, though turnaround varies by lab.
Chorionic Villus Sampling (CVS)
CVS is an invasive procedure performed between weeks 10 and 13. A provider inserts a thin needle through the abdomen or a catheter through the cervix to collect a small tissue sample from the placenta. That tissue contains fetal DNA, which the lab compares to the father’s cheek swab. CVS carries a miscarriage risk of roughly 0.5% to 1%, or about 1 in 100 to 1 in 200 procedures. It’s rarely performed solely for paternity purposes today, given the availability of the noninvasive option.
Amniocentesis
Amniocentesis is typically done between weeks 15 and 20. A provider uses a thin needle guided by ultrasound to withdraw a small amount of amniotic fluid, which contains cells shed by the fetus. Those cells provide the DNA for comparison. The miscarriage risk is lower than CVS, estimated at 0.25% to 0.5% (about 1 in 200 to 1 in 400). Like CVS, amniocentesis is almost never recommended purely for paternity testing anymore unless it’s already being performed for other medical reasons.
Accuracy of Prenatal Results
All three methods compare the same thing: the baby’s DNA against the potential father’s DNA. When performed by an accredited lab, prenatal paternity tests are over 99% accurate for confirming paternity and 100% accurate for excluding a man who is not the father. The noninvasive blood test is just as reliable as the invasive methods for determining paternity, which is why it has largely replaced them.
One important limitation applies to twin or multiple pregnancies. The noninvasive approach analyzes free-floating placental DNA, and with multiples, the DNA from each fetus can complicate the analysis. Research published in Molecular Cytogenetics found that the screening performance of cell-free DNA analysis is notably weaker in twin pregnancies than in singleton pregnancies. If you’re carrying multiples, discuss your options with a provider, as invasive sampling or post-birth testing may be more appropriate.
What the Process Looks Like
For the noninvasive test, the mother visits a lab or clinic for a standard blood draw from the arm, similar to routine prenatal bloodwork. The potential father provides a cheek swab, either at the same facility or at a separate location. Some companies ship cheek swab kits directly to the father if he’s in a different city. Both samples are sent to the lab, where technicians extract and compare the DNA profiles. You’ll receive results stating either that the tested man is the biological father (with a probability above 99%) or that he is excluded as the father.
For CVS or amniocentesis, the procedure takes place in a hospital or specialized clinic with ultrasound guidance. These appointments are more involved, lasting 30 to 45 minutes, and your provider may recommend resting for the remainder of the day afterward.
Legal Admissibility
Not all prenatal paternity tests hold up in court. The difference comes down to chain of custody. For results to be legally admissible in custody, child support, or immigration cases, samples must be collected at a certified facility where staff verify the identity of each person providing a sample. The collection process is documented at every step so the results can’t be disputed later.
If you order an at-home or “peace of mind” test, you collect samples yourself without identity verification. These results can tell you the answer privately, but a court won’t accept them. Labs accredited by the AABB (formerly the American Association of Blood Banks) meet the highest industry standards for relationship testing. If there’s any chance you’ll need results for legal purposes, choose a legal test from the start. Converting an informal result into a court-accepted one means repeating the entire process.
Cost and Insurance Coverage
Prenatal paternity testing is the most expensive form of paternity testing. The noninvasive blood test typically costs between $800 and $2,000, depending on the lab, turnaround speed, and whether you need legally admissible results. Invasive procedures cost more when you factor in the medical facility fees, ultrasound, and provider charges, with total costs sometimes exceeding $2,500.
Health insurance, Medicare, and Medicaid do not cover paternity testing. Insurers classify it as elective rather than medically necessary, so the full cost is out of pocket. Some labs offer payment plans, and a few will split the cost between the mother and alleged father if both parties agree. If an invasive procedure like amniocentesis is being performed for a separate medical reason (such as screening for chromosomal conditions) and paternity analysis is added on, only the medical portion of the procedure may be partially covered.
Timing at a Glance
- NIPP (noninvasive blood test): available from week 8, no risk to pregnancy
- CVS: weeks 10 to 13, small miscarriage risk (0.5% to 1%)
- Amniocentesis: weeks 15 to 20, smaller miscarriage risk (0.25% to 0.5%)
If you want answers as early as possible with the least risk, the noninvasive blood test at 8 weeks is the standard choice. The invasive options are worth considering only when those procedures are already planned for other prenatal diagnostic reasons.